key: cord-0876959-6l9xuvo4 authors: von Haehling, Stephan; Foldes, Gabor; Papp, Zoltan; Anker, Stefan D. title: Creating an impact, not an impression: ESC Heart Failure in its seventh year date: 2021-10-07 journal: ESC Heart Fail DOI: 10.1002/ehf2.13636 sha: c345751f083dd3e5707b95861535913c9c9ea171 doc_id: 876959 cord_uid: 6l9xuvo4 nan We started ESC Heart Failure as the first open access heart failure journal in September 2014, and we would have never guessed that this journal would produce such a great interest in the heart failure community. Indeed, the first ever article to be published in ESC Heart Failure-by this group of authors-already noted that 'research in acute and chronic heart failure is busier than ever worldwide and demands more publishing space'. 1 Obviously, our starting conditions were a little easier than for many other new journals with a grown-up sister journal published already for decades, the European Journal of Heart Failure, that would allow transfer to the new journal for submissions that could not be published, mostly for lack of space. Soon, the journal was indexed in PubMed, and in 2018, the first ever Impact Factor was released for ESC Heart Failure, reaching 3.407. Despite increasing submission numbers expected to grow to 1500 this year alone, we are extremely pleased to say that the impact factor has increased to 4.411 when it was published in June this year. Looking into PubMed, a search of 'ESC Heart Fail [JO]' yields 1,424 results. Papers cover a very broad range of heart failure research from basic research over to randomized controlled trials, systematic reviews, review articles, case reports as well as rationale & design papers, and subanalyses of large-scale clinical trials. With an increasing submission rate and a decreasing acceptance rate that still is about 50% of all submissions, we always aim to broaden clinical and basic research understanding of heart failure in its largest sense. Not surprisingly, the best cited paper in ESC Heart Failure published in 2020 by Felicitas Escher et al. was a paper on the detection of SARS-CoV-2 genomes, which was published while the pandemic was still raging. These authors used E D I T O R I A L Vallabhajosyula et al. 4 Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock 2020 Martín-Garcia et al. 5 Effectiveness of sacubitril-valsartan in cancer patients with heart failure 2020 Patel et al. 6 Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension 2020 Zannad et al. 7 Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study 2020 Salvioni et al. 8 Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 2020 Michel et al. 9 Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis 2020 Schramm et al. 10 Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3® 2020 Karaye et al. 11 Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry 2020 endomyocardial biopsies of 104 patients with suspected myocarditis or unexplained heart failure to detect SARS-Cov-2 genomes by real-time reversed transcriptase polymerase chain reaction and found that five samples contained SARS-CoV-2. These findings were suggestive of myocardial injury based in SARS-CoV-2 accumulation in the myocardium, ultimately leading to ubiquitous troponin increase. 2 Other papers having received high citation rates are listed in Table 1 . The table also highlights the broad spectrum of topics covered by the Journal. Of course, the impact factor has been a matter of debate since its first release in 1975 after being originally suggested by Eugene Garfield. To understand how the impact factor is devised, it needs to be considered that only articles are taken into consideration that have been published 2 years before publication of the respective impact factor, for example, in June this year, the 2020 impact factor was released taking into account all publications in ESC Heart Failure published in 2018 and 2019 and the citations to these manuscripts also gained in 2018 and 2019. This point also highlights the fact that the 2 year impact factor may be useful for research with rapid turnover such as heart failure but not for other areas. Real 'impact' may sometimes be better reflected by the 5 year impact factor that is also published by Clarivate Analyticsthe current publisher of the journal impact factor after Thomson Scientific and Healthcare sold this part of their portfolio in 2018. 12 Anyhow, as the editors of ESC Heart Failure, we are proud to have an impact factor above 4 giving us a solid foundation among other heart failure journals for future publications ( Table 2) , and we continue to welcome manuscripts from the field of heart failure in its broadest sense. Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies Pulmonary artery catheter use in acute myocardial infarctioncardiogenic shock Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock Effectiveness of sacubitril-valsartan in cancer patients with heart failure Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Ab-bott® HeartMate 3® PEACE Registry Investigators. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry On the pitfalls of journal ranging by Impact Factor